Home48Q • FRA
add
X4 Pharmaceuticals Inc
Previous close
€0.88
Day range
€0.85 - €0.87
Year range
€0.56 - €2.30
Market cap
155.86M USD
Avg Volume
1.33K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 37.29M | 27.25% |
Net income | -51.77M | -115.51% |
Net profit margin | — | — |
Earnings per share | -0.26 | -62.50% |
EBITDA | -37.23M | -27.59% |
Effective tax rate | -0.04% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 80.87M | -13.42% |
Total assets | 112.18M | -9.83% |
Total liabilities | 111.15M | 52.82% |
Total equity | 1.04M | — |
Shares outstanding | 167.94M | — |
Price to book | 87.70 | — |
Return on assets | -71.86% | — |
Return on capital | -110.52% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -51.77M | -115.51% |
Cash from operations | -33.60M | -26.72% |
Cash from investing | -5.32M | -59,033.33% |
Cash from financing | — | — |
Net change in cash | -38.98M | -36.31% |
Free cash flow | -20.44M | -20.70% |
About
Founded
Mar 13, 2019
Headquarters
Website
Employees
116